dc.contributorde-la-Torre, Alejandra
dc.creatorGuayacan_Daza, Carol
dc.creatorGalindo_Mendez, Brahyan
dc.date.accessioned2017-08-19T08:21:07Z
dc.date.available2017-08-19T08:21:07Z
dc.date.created2017-08-19T08:21:07Z
dc.date.issued2017
dc.identifierhttp://repository.urosario.edu.co/handle/10336/13703
dc.identifierhttps://doi.org/10.48713/10336_13703
dc.description.abstractPurpose: To describe the clinical presentation of Vogt-Koyanagi-Harada syndrome in a group of patients in Colombia. Methods: Retrospective-review of 2638 medical-records of patients with uveitis in two centers during 17 years. Results: Twenty-five patients with uveitis were diagnosed with Vogt-Koyanagi-Harada syndrome (0. 95%), 23 patients were included in the data analysis (0. 87%), 78. 3% females, mean age of diagnosis 37 years old (SD ±29). Main complaints: blurred vision (87%), headaches (47. 8%), tinnitus (26. 1%) and hearing impairments (21. 7%). Ophthalmic findings: bilateral serous retinal-detachment (73. 9%), non-granulomatous uveitis (52. 3%). Most of the patients were diagnosed with probable disease (56. 5%). Mean duration of follow-up was fourteen months; disease relapse was encountered in 26% of patients despite treatment. Conclusion: Patients in Colombia with Vogt-Koyanagi-Harada had clinical features similar to those reported in other Hispanic populations, except for the non-granulomatous uveitis. This disease may be considered as having variation of clinical manifestations across population groups.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Oftalmología
dc.publisherFacultad de Medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto completo)
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceMoorthy RS, Inomata H RN. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;Jan-Feb(39(4)):265–92.
dc.sourceRead RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–52
dc.sourceXu M, Wang C, Tian Y, Kijlstra A, Yang P. Inhibition of Proinflammatory Cytokine by IL-25 in Vogt-Koyanagi-Harada Syndrome. Ocul Immunol Inflamm [Internet]. Informa Clin Med; 2013 Dec 11;22(4):294–9. Available from: http://dx.doi.org/10.3109/09273948.2013.854391
dc.sourceHerbort CP, Mochizuki M. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol. 2007;27(2–3):67–79.
dc.sourceDe-Domingo B, Blanco MJ, Rodríguez-Cid MJ, Piñeiro A, Mera P, Capeáns MC. [Vogt Koyanagi Harada syndrome]. Arch Soc Esp Oftalmol. 2008 Jun;83(6):385–90.
dc.sourceSukavatcharin S, Tsai JH, Rao N a. Vogt-Koyanagi-Harada disease in Hispanic patients. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):143–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17380271
dc.sourceCardoso I ZM. Applicability of the 2001 revised diagnostic criteria in Brazilian Vogt-Koyanagi-Harada disease patients. Arq Bras Oftalmol. 2008;71(1):67–70.
dc.sourcede-la-Torre A, López-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya J-M. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Experiment Ophthalmol. 2009 Jul;37(5):458–66.
dc.sourcePan D, Hirose T. Vogt-Koyanagi-Harada syndrome: review of clinical features. Semin Ophthalmol. 2011;26(4–5):312–5.
dc.sourceda Silva FTBGC, Damico FM, Marin ML, Goldberg AC, Hirata CE, Takiuti PH, et al. Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories. Am J Ophthalmol [Internet]. Elsevier Inc.; 2009 Feb [cited 2014 Feb 1];147(2):339–345.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18992868
dc.sourceFang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye Res. 2008 Jul;33(7):517–23
dc.sourceChee S-P, Jap A, Bacsal K. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol. 2009 Jan;147(1):154–161.e1.
dc.sourceBordaberry MF. Vogt-Koyanagi-Harada disease: diagnosis and treatments update. Curr Opin Ophthalmol. 2010 Nov;21(6):430–5.
dc.sourceSoheilian M, Aletaha M, Yazdani S, Dehghan MH, Peyman GA. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis. Ocul Immunol Inflamm. 2006 Apr;14(2):91–8.
dc.sourceKiyomoto C, Imaizumi M, Kimoto K, Abe H, Nakano S, Nakatsuka K. Vogt-Koyanagi-Harada disease in elderly Japanese patients. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):149–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17437061
dc.sourceTugal-Tutkun I, Ozyazgan Y, Akova Y a, Sullu Y, Akyol N, Soylu M, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):117–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16957877
dc.sourceRao N a, Sukavatcharin S, Tsai JH. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):195–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17384920
dc.sourceAbad S, Monnet D, Caillat-Zucman S, Mrejen S, Blanche P, Chalumeau M, et al. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm [Internet]. 2008 [cited 2014 Feb 1];16(1):3–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18379934
dc.sourceMurthy SI, Moreker MR, Sangwan VS, Khanna RC, Tejwani S. The spectrum of Vogt-Koyanagi-Harada disease in South India. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):131–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17318321
dc.sourceAbu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91(6):486–93.
dc.sourceSakata VM, Silva FT, Hirata CE, Marin MLC, Rodrigues H, Kalil J, et al. High rate of clinical recurrence in patients with Vogt – Koyanagi – Harada disease treated with early high-dose corticosteroids. Graefes Arch Clin Exp Ophthalmol. 2015;16 January(Published online).
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectVogt-Koyanagi-Harada
dc.subjectUveomeníngeo
dc.subjectDesprendimiento seroso retina
dc.subjectUveítis
dc.subjectCaracterísticas clínicas
dc.subjectColombia
dc.subjectEpidemiología
dc.titleVogt-koyanagi-harada syndrome in a group of patients in two ophthalmology referral centers in Bogota, Colombia
dc.typemasterThesis


Este ítem pertenece a la siguiente institución